Table 3.

Results of analysis of papers studying the prognostic value of NLR in resected pancreatic cancer

Author	Year	NLR	Cut off value	Number	Median survival & range (months)	Disease free survival (months)	Univariate analysis	Multivariate analysis
Stotz, M29	2013	Low	<5	73	21.25b		HR 1.852 (P = 0.006)	HR 1.611 (P = 0.039)
		High	≥5	37	11.2b
Hamed, M30	2013	Low	<5	67	20.6 (11–36.6)		0.153	Not performed
		High	≥5	18	11.3 (8.1–26.3)
La Torre, M31	2012	Low	<5	81	21		0.13	Not performed
		High	≥5	21	17
Sanjay, P32	2012	Low	≤5	38	16.2 (3–63)		P = 0.272	Not performed
		High	>5	13	9.18 (3–70)
Jamieson, NB33	2011	Low	<5	105	20.9 (15.5–26.3a)		P = 0.51	Not performed
		High	≥5	30	25.7 (16.2–35.1a)
Garcea, G34	2011	Low	<5	50		52	P = 0.0057	Not performed
		High	>5	24		12
Bhatti, I35	2010	Low	≤4	71	14 (13.0–15.8)		HR 1.784 (P = 0.023)	HR 1.21 (P = 0.039)
		High	>4	13	7.1 (1.4–12.9)
Clark, E37	2007	Low	<5	40	10.5 (7.1–21.2)		P = 0.16	Not performed
		High	≥5	4	8.9 (5.3–13.3)

NLR, neutrophil–lymphocyte ratio.

^a95% confidence interval,

^bextrapolated from Kaplan–Meier survival curves.